Exact Sciences Corp
NASDAQ:EXAS
Exact Sciences Corp
NASDAQ:EXAS
Price:
51 USD
1.23%
Market Closed
Updated:
May 21, 2024
Exact Sciences Corp
Interest Income Expense
|
Exact Sciences Corp
Interest Income Expense Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Exact Sciences Corp
NASDAQ:EXAS
|
Interest Income Expense
$6.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
37%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Interest Income Expense
-$1.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Interest Income Expense
-$663m
|
CAGR 3-Years
38%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-8%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Interest Income Expense
-$2.9B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-16%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Interest Income Expense
$630.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Interest Income Expense
$221.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is Exact Sciences Corp's Interest Income Expense?
Interest Income Expense
6.9m
USD
6.9m
USD
Based on the financial report for Mar 31, 2024, Exact Sciences Corp's Interest Income Expense amounts to 6.9m USD.
What is Exact Sciences Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
37%
37%
The average annual Interest Income Expense growth rates for Exact Sciences Corp have been -29% over the past three years , and 37% over the past ten years .
You don't have any saved screeners yet
